Repros Therapeutics, Inc. (RPRX)

[exwannabe]

io, you got your math backwards on the 10%

With enough rats and the right criterion you could have 10% chance of a false failure, and .00000000000001% chance of a false pass. The 10% does not imply there is a 10% possibility the drug is carcinigenic.

Of course, your latter point about the number of rats seams very valid.

Clark, any coments as to why a company couldn't just increase the N on these trials?

Hopefully the sponsor doesn't need to get signed consent forms